Transcend Therapeutics, Inc. is engaged in the development of pharmaceuticals for the treatment of diseases caused by oxidative stress and resultant tissue damage. The company is engaged in the development of pharmaceuticals for the treatment of diseases caused by oxidative stress and resultant tissue damage. Transcend Therapeutics was established in 1992 in Waltham, Massachusetts.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

Kyowa Hakko Bio Co. Ltd. engages in the manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use. The company was founded on October 1, 2008 and is headquartered in Tokyo, Japan.

Takara Bio Inc., develops, manufactures, and distributes a wide range of life science reagents and kits under the Takara®, Clontech®, and Cellartis® brands. Key products include SMART® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cells and stem cell reagents; RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; and Living Colors® fluorescent proteins. These and other products support applications including NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi, gene editing, and stem cell studies; and plant and food research

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

Max International LLC is an American private company located in Midvale, UT. The firm provides healthcare services.

TCI Co., Ltd. engages in the research, development, manufacturing, and sales of health foods and care products. The firm's products include function drinks for beauty, slim, health and energy, function foods in double-layered tablets, capsules, microencapsulated beads and sachet, cosmetics and care products, including creams, bio-cellulose masks, sprays and mousses, and dietary supplements. It operates through the following geographical segments: Taiwan, Asia, and Other. The company was founded on August 22, 1980 and is headquartered in Taipei, Taiwan.

Takara Shuzo Co. Ltd. manufactures and markets alcoholic beverages. Its products include alcoholic beverages, raw alcohol, health drinks, and seasonings. The company was founded in 1925 and is headquartered in Kyoto, Japan.

Linyi Shansong Pharmaceutical Co., Ltd., established on 2004-07-28, Business range includes tablet,hard capsule,Production and sales of food additives(The validity period is subject to the license);Production and sales of crabapple tea,Health tea,substitute tea(The validity period is subject to the license),Formula food for special medical purpose;Wholesale and retail of prepackaged food(The validity period is subject to the license);Warehousing Services(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Research Development Foundation is an American private company that operates as noncommercial research organizations.

Zhenjiang Deer Biological Products Research Institute Co., Ltd., established on 2009-11-09, Business scope includes licensed projects:food production;Health food production;Production of formula food for special medical purpose;food business;Health food sales;Sales of formula food for special medical purposes;Food Internet Sales;beverage production;Cosmetic production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Biochemical product technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Cosmetics Retail;Sales of hygiene products and single-use medical products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Changzhou Qianhong Biopharma Co., Ltd. engages in the research and development, production, and sale of bio-pharmaceutical products. It focuses on polysaccharides and enzymes. Its business scope covers lyophilized powder for injections, small volume parenteral solutions, tablets, hard capsules, granules, and active pharmaceutical ingredient (API) products. The company was founded in 1979 and is headquartered in Changzhou, China.

Zambon is a multinational pharmaceutical and chemical company that focuses on innovation and development with the aim to improve the quality of people’s health and patients’ lives. Based on a valuable heritage but strongly focused on the future, its Vision is “Innovating cure and care to make patients’ lives better”. Zambon operates in the pharmaceutical and chemical business and is present in 20 countries with subsidiaries in three different Continents – Europe, America and Asia – and almost 2800 employees, with manufacturing units in Italy, Switzerland, France, China, and Brazil. Zambon products are commercialized in 84 countries. The company is currently pursuing a new challenge, working on the treatment of specialties and rare diseases, such as Parkinson’s disease and Cystic Fibrosis and is well-established in 3 therapeutic areas: respiratory, pain and women’s care. Zambon produces high-quality products thanks to the management of the whole production chain which involves Zach (Zambon chemical), a privileged partner for API, custom synthesis and generic products. Recognizing the ever-growing importance of innovative technologies and the digitalization of healthcare, Zambon complements the offering of medicines with modern health solutions, in order to translate its vision into concrete actions. Zcube - Zambon Research Venture - is actively scouting for modern health solutions in the field of drug delivery systems, medical devices, biomarkers, diagnostics, digital health, and big data solutions. Zambon was established in 1906 in Vicenza and is headquartered in Milan within OpenZone, a scientific campus founded with the aim to create an entrepreneurial ecosystem where the knowledge is shared between partners in the field of Life Sciences.

Jinan Maternity & Children Health Hospital is a Chinese private company located in Jinan. The firm provides health care services.

Noevir Co., Ltd. is engaged in the manufacture and sale of cosmetics, pharmaceutical products and dietary supplement as well as sale of cosmetic accessories. It operates in Cosmetics, Pharmaceutical Products, Food and Others business division. The Cosmetics division is engaged in the manufacture and sale of cosmetics and toiletries, as well as sale of cosmetic accessories. The Pharmaceutical Products division is engaged in the manufacture and sale of pharmaceutical products. The Food division is engaged in the manufacture and sale of dietary supplement. The Others division is engaged in the purchase and sale of apparel, aircraft and ships, as well as the non regular air freight service. The company was founded in April 1964 and is headquartered in Kobe, Japan.

Suntory Holdings Ltd. operates as a holding company with interests in the production and distribution of alcoholic and non-alcoholic beverages, health, beauty, and processed food products. Its services include formulation and promotion of group wide management strategies and corporate functions; sale of alcoholic beverages such as whiskey, beer, and wine; soft drinks; and other beverages such as tea and canned coffee. The company was founded by Shinjiro Torii in 1899 and is headquartered in Osaka, Japan.